Global Lixisenatide Market Insights, Forecast to 2025
- QYR2792314
- 112 Pages
- October 2018
- Pharmaceuticals
The growth of the global lixisenatide market is driven by increase in prevalence diabetes and surge in overweight populace.
Moreover, unhealthy urban lifestyle and increase number of fast food eating populace susceptible to sudden weight gain are expected to boost the market growth.
However, number of limited manufacturers and distribution channels is anticipated to impede the market growth.
In 2017, the global Lixisenatide market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Lixisenatide market based on company, product type, application and key regions.
This report studies the global market size of Lixisenatide in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Lixisenatide in these regions.
This research report categorizes the global Lixisenatide market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.
The various contributors involved in the value chain of Lixisenatide include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Lixisenatide include
Zealand Pharma
Sanofi-Aventis
Market Size Split by Type
Industrial Grade
Pharmaceutical Grade
Market Size Split by Application
Hospital
Clinic
Medical center
Others
Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Lixisenatide market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Lixisenatide market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Lixisenatide manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Lixisenatide with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Lixisenatide submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Lixisenatide are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Lixisenatide market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Study Coverage
1.1 Lixisenatide Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Lixisenatide Market Size Growth Rate by Type
1.4.2 Industrial Grade
1.4.3 Pharmaceutical Grade
1.5 Market by Application
1.5.1 Global Lixisenatide Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Medical center
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Lixisenatide Market Size
2.1.1 Global Lixisenatide Revenue 2016-2025
2.1.2 Global Lixisenatide Sales 2016-2025
2.2 Lixisenatide Growth Rate by Regions
2.2.1 Global Lixisenatide Sales by Regions
2.2.2 Global Lixisenatide Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Lixisenatide Sales by Manufacturers
3.1.1 Lixisenatide Sales by Manufacturers
3.1.2 Lixisenatide Sales Market Share by Manufacturers
3.1.3 Global Lixisenatide Market Concentration Ratio (CR5 and HHI)
3.2 Lixisenatide Revenue by Manufacturers
3.2.1 Lixisenatide Revenue by Manufacturers (2016-2018)
3.2.2 Lixisenatide Revenue Share by Manufacturers (2016-2018)
3.3 Lixisenatide Price by Manufacturers
3.4 Lixisenatide Manufacturing Base Distribution, Product Types
3.4.1 Lixisenatide Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Lixisenatide Product Category
3.4.3 Date of International Manufacturers Enter into Lixisenatide Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Lixisenatide Sales by Type
4.2 Global Lixisenatide Revenue by Type
4.3 Lixisenatide Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Lixisenatide Breakdown Data by Application
6 North America
6.1 North America Lixisenatide by Countries
6.1.1 North America Lixisenatide Sales by Countries
6.1.2 North America Lixisenatide Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Lixisenatide by Type
6.3 North America Lixisenatide by Application
6.4 North America Lixisenatide by Company
7 Europe
7.1 Europe Lixisenatide by Countries
7.1.1 Europe Lixisenatide Sales by Countries
7.1.2 Europe Lixisenatide Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Lixisenatide by Type
7.3 Europe Lixisenatide by Application
7.4 Europe Lixisenatide by Company
8 Asia Pacific
8.1 Asia Pacific Lixisenatide by Countries
8.1.1 Asia Pacific Lixisenatide Sales by Countries
8.1.2 Asia Pacific Lixisenatide Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Lixisenatide by Type
8.3 Asia Pacific Lixisenatide by Application
8.4 Asia Pacific Lixisenatide by Company
9 Central & South America
9.1 Central & South America Lixisenatide by Countries
9.1.1 Central & South America Lixisenatide Sales by Countries
9.1.2 Central & South America Lixisenatide Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Lixisenatide by Type
9.3 Central & South America Lixisenatide by Application
9.4 Central & South America Lixisenatide by Company
10 Middle East and Africa
10.1 Middle East and Africa Lixisenatide by Countries
10.1.1 Middle East and Africa Lixisenatide Sales by Countries
10.1.2 Middle East and Africa Lixisenatide Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Lixisenatide by Type
10.3 Middle East and Africa Lixisenatide by Application
10.4 Middle East and Africa Lixisenatide by Company
11 Company Profiles
11.1 Zealand Pharma
11.1.1 Zealand Pharma Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Lixisenatide
11.1.4 Lixisenatide Product Description
11.1.5 Recent Development
11.2 Sanofi-Aventis
11.2.1 Sanofi-Aventis Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Lixisenatide
11.2.4 Lixisenatide Product Description
11.2.5 Recent Development
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Lixisenatide Raw Material
13.1.2 Lixisenatide Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
Figure Picture of Lixisenatide
Figure Global Lixisenatide Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Lixisenatide Production Market Share by Types (Product Category) in 2017
Figure Industrial Grade Product Picture
Table Major Manufacturers of Industrial Grade
Figure Pharmaceutical Grade Product Picture
Table Major Manufacturers of Pharmaceutical Grade
Table Global Lixisenatide Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Hospital
Figure Clinic
Figure Medical center
Figure Others
Figure Lixisenatide Report Years Considered
Figure Global Lixisenatide Market Size 2016-2025 (Million US$)
Figure Global Lixisenatide Sales 2016-2025 (K Units)
Table Global Lixisenatide Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Lixisenatide Sales by Regions 2016-2025 (K Units)
Table Global Lixisenatide Sales Market Share by Regions 2016-2025
Figure Global Lixisenatide Sales Market Share by Regions 2016-2025
Figure 2017 Global Lixisenatide Sales Market Share by Regions
Table Global Lixisenatide Revenue by Regions 2016-2025 (Million US$)
Table Global Lixisenatide Revenue Market Share by Regions 2016-2025
Figure Global Lixisenatide Revenue Market Share by Regions 2016-2025
Figure 2017 Global Lixisenatide Revenue Market Share by Regions
Table Global Lixisenatide Sales by Manufacturers (2016-2018) (K Units)
Table Global Lixisenatide Sales Share by Manufacturers (2016-2018)
Figure Global Lixisenatide Sales Share by Manufacturers in 2017
Table Lixisenatide Revenue by Manufacturers (2016-2018) (Million US$)
Table Lixisenatide Revenue Share by Manufacturers (2016-2018)
Figure Lixisenatide Value Share by Manufacturers in 2017
Table Global Lixisenatide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Lixisenatide Price (2016-2018) (USD/Unit)
Table Lixisenatide Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Lixisenatide Product Category
Table Date of International Manufacturers Enter into Lixisenatide Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Lixisenatide Sales by Type (2016-2025) (K Units)
Table Global Lixisenatide Sales Share by Type (2016-2025)
Figure Global Lixisenatide Sales Market Share by Type (2016-2025)
Figure Global Lixisenatide Sales Market Share by Type in 2017
Table Global Lixisenatide Revenue by Type (2016-2025) (Million US$)
Table Global Lixisenatide Revenue Share by Type (2016-2025)
Figure Global Lixisenatide Revenue Market Share by Type (2016-2025)
Figure Global Lixisenatide Revenue Market Share by Type in 2017
Table Lixisenatide Price by Type 2013-2018 (USD/Unit)
Table Global Lixisenatide Sales by Application (2016-2025) (K Units)
Table Global Lixisenatide Sales Share by Application (2016-2025)
Figure Global Sales Lixisenatide Market Share by Application (2016-2025)
Figure Global Sales Lixisenatide Market Share by Application (2016-2025)
Figure North America Lixisenatide Sales Growth Rate 2016-2025 (K Units)
Figure North America Lixisenatide Revenue Growth Rate 2016-2025 (Million US$)
Table North America Lixisenatide Sales by Countries (2016-2025) (K Units)
Table North America Lixisenatide Sales Market Share by Countries (2016-2025)
Figure 2017 North America Lixisenatide Sales Market Share by Countries
Table North America Lixisenatide Revenue by Countries (2016-2025) (Million US$)
Table North America Lixisenatide Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Lixisenatide Revenue Market Share by Countries
Figure United States Lixisenatide Sales Growth Rate (2016-2025) (K Units)
Figure United States Lixisenatide Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Lixisenatide Sales Growth Rate (2016-2025) (K Units)
Figure Canada Lixisenatide Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Lixisenatide Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Lixisenatide Revenue Growth Rate (2016-2025) (Million US$)
Table North America Lixisenatide Sales by Type (2016-2025) (K Units)
Table North America Lixisenatide Sales Market Share by Type (2016-2025)
Figure 2017 North America Lixisenatide Market Share by Type
Table North America Lixisenatide Sales by Application (2016-2025) (K Units)
Table North America Lixisenatide Sales Market Share by Application (2016-2025)
Figure 2017 North America Lixisenatide Market Share by Application
Table North America Lixisenatide Sales by Company (2016-2018) (K Units)
Table North America Lixisenatide Sales Market Share by Company (2016-2018)
Figure North America Lixisenatide Sales Market Share by Company in 2017
Figure Europe Lixisenatide Sales Growth Rate 2016-2025 (K Units)
Figure Europe Lixisenatide Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Lixisenatide Sales by Countries (2016-2025) (K Units)
Table Europe Lixisenatide Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Lixisenatide Sales Market Share by Countries
Table Europe Lixisenatide Revenue by Countries (2016-2025) (Million US$)
Table Europe Lixisenatide Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Lixisenatide Revenue Market Share by Countries
Figure Germany Lixisenatide Sales Growth Rate (2016-2025) (K Units)
Figure Germany Lixisenatide Revenue Growth Rate (2016-2025) (K Units)
Figure France Lixisenatide Sales Growth Rate (2016-2025) (K Units)
Figure France Lixisenatide Revenue Growth Rate (2016-2025) (K Units)
Figure UK Lixisenatide Sales Growth Rate (2016-2025) (K Units)
Figure UK Lixisenatide Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Lixisenatide Sales Growth Rate (2016-2025) (K Units)
Figure Italy Lixisenatide Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Lixisenatide Sales Growth Rate (2016-2025) (K Units)
Figure Russia Lixisenatide Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Lixisenatide Sales by Type (2016-2025) (K Units)
Table Europe Lixisenatide Sales Market Share by Type (2016-2025)
Figure 2017 Europe Lixisenatide Market Share by Type
Table Europe Lixisenatide Sales by Application (2016-2025) (K Units)
Table Europe Lixisenatide Sales Market Share by Application (2016-2025)
Figure 2017 Europe Lixisenatide Market Share by Application
Table Europe Lixisenatide Sales by Company (2016-2018) (K Units)
Table Europe Lixisenatide Sales Market Share by Company (2016-2018)
Figure Europe Lixisenatide Sales Market Share by Company in 2017
Figure Asia Pacific Lixisenatide Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Lixisenatide Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Lixisenatide Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Lixisenatide Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Lixisenatide Sales Market Share by Countries
Table Asia Pacific Lixisenatide Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Lixisenatide Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Lixisenatide Revenue Market Share by Countries
Figure China Lixisenatide Sales Growth Rate (2016-2025) (K Units)
Figure China Lixisenatide Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Lixisenatide Sales Growth Rate (2016-2025) (K Units)
Figure Japan Lixisenatide Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Lixisenatide Sales Growth Rate (2016-2025) (K Units)
Figure Korea Lixisenatide Revenue Growth Rate (2016-2025) (Million US$)
Figure India Lixisenatide Sales Growth Rate (2016-2025) (K Units)
Figure India Lixisenatide Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Lixisenatide Sales Growth Rate (2016-2025) (K Units)
Figure Australia Lixisenatide Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Lixisenatide Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Lixisenatide Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Lixisenatide Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Lixisenatide Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Lixisenatide Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Lixisenatide Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Lixisenatide Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Lixisenatide Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Lixisenatide Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Lixisenatide Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Lixisenatide Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Lixisenatide Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Lixisenatide Sales by Type (2016-2025) (K Units)
Table Asia Pacific Lixisenatide Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Lixisenatide Market Share by Type
Table Asia Pacific Lixisenatide Sales by Application (2016-2025) (K Units)
Table Asia Pacific Lixisenatide Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Lixisenatide Market Share by Application
Table Asia Pacific Lixisenatide Sales by Company (2016-2018) (K Units)
Table Asia Pacific Lixisenatide Sales Market Share by Company (2016-2018)
Figure Asia Pacific Lixisenatide Sales Market Share by Company in 2017
Figure Central & South America Lixisenatide Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Lixisenatide Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Lixisenatide Sales by Countries (2016-2025) (K Units)
Table Central & South America Lixisenatide Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Lixisenatide Sales Market Share by Countries
Table Central & South America Lixisenatide Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Lixisenatide Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Lixisenatide Revenue Market Share by Countries
Figure Brazil Lixisenatide Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Lixisenatide Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Lixisenatide Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Lixisenatide Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Lixisenatide Sales by Type (2016-2025) (K Units)
Table Central & South America Lixisenatide Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Lixisenatide Market Share by Type
Table Central & South America Lixisenatide Sales by Application (2016-2025) (K Units)
Table Central & South America Lixisenatide Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Lixisenatide Market Share by Application
Table Central & South America Lixisenatide Sales by Company (2016-2018) (K Units)
Table Central & South America Lixisenatide Sales Market Share by Company (2016-2018)
Figure Central & South America Lixisenatide Sales Market Share by Company in 2017
Figure Middle East and Africa Lixisenatide Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Lixisenatide Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Lixisenatide Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Lixisenatide Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Lixisenatide Sales Market Share by Countries
Table Middle East and Africa Lixisenatide Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Lixisenatide Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Lixisenatide Revenue Market Share by Countries
Figure GCC Countries Lixisenatide Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Lixisenatide Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Lixisenatide Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Lixisenatide Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Lixisenatide Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Lixisenatide Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Lixisenatide Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Lixisenatide Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Lixisenatide Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Lixisenatide Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Lixisenatide Market Share by Type
Table Middle East and Africa Lixisenatide Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Lixisenatide Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Lixisenatide Market Share by Application
Table Middle East and Africa Lixisenatide Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Lixisenatide Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Lixisenatide Sales Market Share by Company in 2017
Table Zealand Pharma Company Details
Table Zealand Pharma Lixisenatide Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Zealand Pharma Recent Development
Table Sanofi-Aventis Company Details
Table Sanofi-Aventis Lixisenatide Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sanofi-Aventis Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Lixisenatide Value Chain
Table Typical Suppliers of Key Lixisenatide Raw Material
Table Lixisenatide Customers List
Table Lixisenatide Sales Channels
Table Lixisenatide Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
